Search Tag: breast cancer

IMAGING Management

Dce-mri-technique-to-predict-breast-cancer-recurrence-risk

2024 29 Jan

A groundbreaking study led by Dr Dooman Arefan from the University of Pittsburgh has unveiled a promising method for predicting breast cancer recurrence risk. The research, published in Radiology , sheds light on how quantitative background parenchymal enhancement (BPE) measurements at dynamic contrast-enhanced MRI (DCE-MRI) could predict the...Read more

Women's Health

Dce-mri-technique-to-predict-breast-cancer-recurrence-risk

2024 29 Jan

A groundbreaking study led by Dr Dooman Arefan from the University of Pittsburgh has unveiled a promising method for predicting breast cancer recurrence risk. The research, published in Radiology , sheds light on how quantitative background parenchymal enhancement (BPE) measurements at dynamic contrast-enhanced MRI (DCE-MRI) could predict the...Read more

IMAGING Management

B-rayz-achieves-ce-mark-for-revolutionary-ai-in-breast-diagnostics

2024 22 Jan

b-rayZ, Swiss innovator in  AI-powered medical imaging solution s, proudly announces the receipt of the CE mark for the groundbreaking DANAI technology. Seamlessly integrated into the comprehensive breast diagnostic suites,  b-box  plus,  DANAI empowers breast cancer detection, density assessment and quality-controlled breast positioning.  DANAI marks...Read more

Women's Health

B-rayz-achieves-ce-mark-for-revolutionary-ai-in-breast-diagnostics

2024 22 Jan

b-rayZ, Swiss innovator in  AI-powered medical imaging solution s, proudly announces the receipt of the CE mark for the groundbreaking DANAI technology. Seamlessly integrated into the comprehensive breast diagnostic suites,  b-box  plus,  DANAI empowers breast cancer detection, density assessment and quality-controlled breast positioning.  DANAI marks...Read more

Artificial Intelligence

B-rayz-achieves-ce-mark-for-revolutionary-ai-in-breast-diagnostics

2024 22 Jan

b-rayZ, Swiss innovator in  AI-powered medical imaging solution s, proudly announces the receipt of the CE mark for the groundbreaking DANAI technology. Seamlessly integrated into the comprehensive breast diagnostic suites,  b-box  plus,  DANAI empowers breast cancer detection, density assessment and quality-controlled breast positioning.  DANAI marks...Read more

IMAGING Management

Ai-advances-the-development-of-a-cancer-survival-calculator

2023 03 Nov

According to a new study, presented at the ACS Clinical Congress 2023, researchers have created an AI-driven tool for calculating the long-term survival prospects of recently diagnosed cancer patients.   Estimating survival rates for patients with cancer normally depends on their cancer stage.  However, numerous other factors can influence a...Read more

IMAGING Management

Exploring-the-factors-influencing-breast-radiologists-decision-to-stay-or-go

2023 11 Oct

A recent survey was conducted among breast radiologists to investigate the common factors that impact workplace satisfaction and the chances that breast radiologists leave their jobs.   Members of the Society of Breast Imaging were surveyed about workplace satisfaction, with radiologists specifying recent departures from or contemplation of leaving...Read more

Women's Health

Championing-billions-of-women-through-the-hologic-global-womens-health-index

2023 30 Aug

The invitation proved too momentous to pass up.   It arrived as I reached my third decade in academic medicine, including years of serving as Director of Breast Imaging for Johns Hopkins Medicine. During this entire time, it was a privilege to help thousands of women – and their families – navigate their journeys against breast cancer.  ...Read more

IMAGING Management

Changes-in-breast-density-overtime-signals-breast-cancer-risk

2023 15 May

A recent study suggests that the more time it takes for breast density to decrease, the higher the chance a woman could develop breast cancer.   In the study published in JAMA Oncology, the team used a mathematical model to monitor changes in breast density across a 10-year period in almost 1,000 women. The study revealed the association between...Read more

IMAGING Management

Hologic-statement-on-recently-released-uspstf-breast-cancer-screening-guidelines

2023 09 May

As a leader in women’s health, Hologic knows that increasing access to breast cancer screening is critical to detecting cancer earlier and saving lives.   We commend the U.S. Preventive Services Task Force (USPSTF) for changing their draft guidelines to recommend that women begin screening at age 40. Lowering the age for initial screening to 40...Read more

Women's Health

Hologic-statement-on-recently-released-uspstf-breast-cancer-screening-guidelines-1

2023 09 May

As a leader in women’s health, Hologic knows that increasing access to breast cancer screening is critical to detecting cancer earlier and saving lives.   We commend the U.S. Preventive Services Task Force (USPSTF) for changing their draft guidelines to recommend that women begin screening at age 40. Lowering the age for initial screening to 40...Read more

IMAGING Management

Acr-announces-new-breast-cancer-screening-recommendations

2023 05 May

The American College of Radiology (ACR) have released new breast cancer screening guidelines, recommending earlier and more intensive screening for women at high-risk.   The latest scientific evidence states that all women at higher-than-average risk should undergo risk assessment by age 25 to determine if MRI surveillance is required earlier than...Read more

Ultrasound

Acr-announces-new-breast-cancer-screening-recommendations

2023 05 May

The American College of Radiology (ACR) have released new breast cancer screening guidelines, recommending earlier and more intensive screening for women at high-risk.   The latest scientific evidence states that all women at higher-than-average risk should undergo risk assessment by age 25 to determine if MRI surveillance is required earlier than...Read more

Women's Health

New-findings-will-help-personalise-approaches-to-breast-cancer-screening

2023 08 Feb

A recent study published in the Journal of Clinical Oncology revealed that women with cancer in one breast may be at a higher risk of developing cancer in the opposite breast. This is subject to them being carriers of specific genetic changes that predispose them to develop breast cancer.   Using data from 15,104 women researchers found that...Read more

Women's Health

New-data-presented-at-sabcs-2022-reveal-expanded-predictive-value-of-the-breast-cancer-indextm-test

2022 06 Dec

The Breast Cancer Index Test Is the First Biomarker to Predict Treatment Benefit in the SOFT Trial Hologic , Inc. and its subsidiary, Biotheranostics, Inc., announced new study data showing that the Breast Cancer Index test identified which premenopausal patients with early-stage, hormone-receptor positive (HR+) breast cancer benefited from...Read more

Women's Health

Study-finds-women-with-benign-breast-disease-face-long-term-risk-of-breast-cancer

2022 25 Nov

A population-based study, involving 7778,306 women aged 50-69 years, assesses their risk of breast cancer after participating in at least one mammographic screening. Researchers compared the incident rates of women diagnosed with and without benign breast cancer.   Women involved in the study had taken part in a breast screening between 1996 and...Read more

IMAGING Management

Ncobc-2023-32nd-annual-interdisciplinary-breast-center-conference

2023 24 Mar

Find National Consortium Of Breast Centers on Social Media   Read more

IMAGING Management

The-hologic-supersonictm-machtm-40-introduces-exceptional-image-quality-and-practical-benefits

2022 06 Sep

  Radiologist Dr Georgia Spear of NorthShore Medical Group   The Hologic’s SuperSonic™ MACH™ 40 Ultrasound System brings radiologists a new generation of ultrasound technology.   At times, mammographic findings turn out very subtle. Ultrasounds enhance the detection of these findings, thus improving the accuracy of diagnosis....Read more

Women's Health

Study-reveals-climbing-incidence-rates-of-late-stage-cervical-cancer-in-the-u-s

2022 02 Sep

The human papillomavirus causes more than 95% of cervical cancer (HPV), mostly due to HPV types 16 and 18 (WHO, 2022).In recent decades, the scale-up of cervical cancer screening, HPVtesting, and the drive for HPV vaccinations have massively contributed to reducing cervical cancer incidence in high-income countries (2022).   New research, published...Read more

Women's Health

Racial-disparities-in-breast-cancer-1

2022 30 Jun

New findings published in Cancer Epidemiology Biomarkers & Prevent show significant differences in the accuracy of diagnostic mammograms across racial and ethnic groups, with variation observed in several measures of diagnostic performance.  Several studies have already established that racial disparities exist in breast cancer. Multiple socioeconomic...Read more

Women's Health

Nice-endorses-magnetic-marker-liquid-probe-for-breast-cancer-metastasis

2022 19 May

The UK National Institute for Health and Care Excellence (NICE) now endorses the use of Magtrace and Sentimag magnetic marker liquids to locate sentinel lymph nodes in women with breast cancer in a new draft guidance.   Sentinel lymph nodes are the first lymph nodes that a primary tumour can drain. When the tracer is injected into a tumour, tracer...Read more

Women's Health

Ai-as-second-reader-performs-well-in-breast-cancer-screening

2022 31 Mar

Researchers from the Cancer Registry of Norway demonstrated that a commercial artificial intelligence (AI) system could detect breast cancer from mammographic images and serve as a second reader in a retrospective study published in Radiology . Examining mammograms gathered as part of a population-based breast cancer screening program produces...Read more

Women's Health

Breast-imaging-predictive-and-prognostic-models-ecr-2022

2022 14 Mar

Dr Michael Fuchsjäger, Chairman of the ESR Board of Directors (Graz, Austria) and Iva Biondić Špoljar of University Hospital Dubrava (Zagreb, Croatia) co-moderated a session on predictive and prognostic models in breast imaging. In this session, three experts presented on the use of Magnetic Resonance Imaging (MRI) markers in neoadjuvant chemotherapy for...Read more

Women's Health

Fatigue-hits-inexperienced-breast-radiologists-more

2022 13 Jan

Brown University (Providence, RI) researchers reported in Radiology that fatigue affects less experienced radiologists more for breast cancer screening. Specifically, radiologists with five or fewer years of posttraining experience recommended more imaging when digital breast tomosynthesis (DBT) images were read later in the day.   In breast...Read more

IMAGING Management

Oncology-convention-2022

2022 15 Nov

Find European Oncology Congress on Social Media  Read more

Women's Health

Digital-breast-tomosynthesis-continues-to-perform-well-after-10-years

2021 14 Dec

Over the last ten years, digital breast tomosynthesis (DBT) has continued to provide better cancer detection with fewer false positives than 2D digital mammography. At RSNA 2021, Dr Liane E Philpotts of Yale School of Medicine presented a study comparing DBT’s performance to 2D mammography over a ten-year period.    An X-ray source travels in...Read more

IT Management

Automated-triaging-of-mris-rules-out-cancer-in-dense-breasts

2021 08 Oct

Mammography provides early detection when breast cancer treatments are more successful. Unfortunately, mammography is less sensitive in women with dense than with fatty breast tissue. This is unfortunate because the breast cancer risk is three- to six times higher in dense rather than fatty breast tissue and two times higher than that of the average...Read more

Women's Health

Triple-negative-breast-cancer-advances-in-treatment

2021 18 Apr

Researchers, Yashar Mashayekhi and Amirmohammad Heidari, from the University of Buckingham Medical School (UK) recently presented results from a study “A critical evaluation of Immunotherapeutic Agents for the Treatment of Triple Negative breast cancer.” In the United Kingdom, breast cancer is the most prevalent type in women; the subtype Triple Negative...Read more